These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 11361978)
1. Recruitment underway for oral contraceptive trial. AIDS Patient Care STDS; 1998 May; 12(5):405. PubMed ID: 11361978 [No Abstract] [Full Text] [Related]
2. Oral contraceptive/nevirapine interaction trial, New York and San Francisco. AIDS Treat News; 1998 Mar; (No 290):7. PubMed ID: 11365121 [TBL] [Abstract][Full Text] [Related]
4. Atypical depression as a premonitory symptom of migraine managed by an oral contraceptive. Kawamura S; Sakai A; Endo T; Maruta M Psychiatry Clin Neurosci; 2008 Jun; 62(3):365. PubMed ID: 18588602 [No Abstract] [Full Text] [Related]
5. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary]. MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921 [No Abstract] [Full Text] [Related]
6. Do women respond differently to HIV therapy than men? Newsline People AIDS Coalit N Y; 1998 Dec; ():31. PubMed ID: 11367087 [TBL] [Abstract][Full Text] [Related]
7. Possible antidepressant effect of oral contraceptives: case report. Roy-Byrne P; Rubinow DR; Gold PW; Post RM J Clin Psychiatry; 1984 Aug; 45(8):350-2. PubMed ID: 6540262 [TBL] [Abstract][Full Text] [Related]
8. HIV drug remains unproven without placebo trial. Turner VF Nature; 2005 Mar; 434(7030):137. PubMed ID: 15758970 [No Abstract] [Full Text] [Related]
9. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():58-60. PubMed ID: 15373051 [No Abstract] [Full Text] [Related]
10. Dysmenorrhoea unrelieved by an oral contraceptive. Practitioner; 1968 Jun; 200(200):856-9. PubMed ID: 4871666 [No Abstract] [Full Text] [Related]
11. [Combined antiretroviral therapy with nevirapine of HIV-infected adults]. Kravchenko AV Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542 [No Abstract] [Full Text] [Related]
12. Update on nevirapine: quest for a niche. MacDougall DS J Int Assoc Physicians AIDS Care; 1997 Sep; 3(9):37-43. PubMed ID: 11364713 [TBL] [Abstract][Full Text] [Related]
13. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy. Cohen J Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490 [No Abstract] [Full Text] [Related]
14. Do we still need lead-in dosing of nevirapine in HIV-infected patients who are receiving rifampicin-containing antituberculous therapy? Chang SY; Lin SW; Hung CC Clin Infect Dis; 2009 Nov; 49(9):1452-3; author reply 1453-4. PubMed ID: 19824849 [No Abstract] [Full Text] [Related]
15. Reports on nevirapine threaten public health. Lane HC; Folkers GK; Fauci AS Nat Med; 2005 Mar; 11(3):245. PubMed ID: 15746930 [No Abstract] [Full Text] [Related]
16. [Clinical results and problems of oral contraceptives, a combination of norethindrone and mestranol (2)]. Ueda Y; Hayashi K; Maruo M; Fujii O; Yagi T Saishin Igaku; 1965 Dec; 20(12):3234-53 passim. PubMed ID: 5869520 [No Abstract] [Full Text] [Related]
17. [A short-term trial of Didanosine, stavudine, and nevirapine combination therapy for human immunodeficiency virus infection]. Zheng YH; Yang X; Chang WH Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):390. PubMed ID: 14653126 [No Abstract] [Full Text] [Related]